| 今开：2.1 | 昨收：2.1 |
| 最高：2.1944 | 最低：2.1 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：6.2939274E7 |
AN2 Therapeutics(ANTX)06-22 06:25
$AN2 Therapeutics(ANTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-076406 Size: 17 KB 网页链接查看全文
AN2 Therapeutics(ANTX)03-30 04:25
$AN2 Therapeutics(ANTX)$ 4/A [Amend] Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000192 Size: 4 KB 网页链接查看全文
AN2 Therapeutics(ANTX)03-30 04:25
$AN2 Therapeutics(ANTX)$ 4/A [Amend] Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000193 Size: 16 KB 网页链接查看全文
AN2 Therapeutics(ANTX)03-30 04:25
$AN2 Therapeutics(ANTX)$ 4/A [Amend] Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000195 Size: 4 KB 网页链接查看全文
AN2 Therapeutics(ANTX)03-30 04:25
$AN2 Therapeutics(ANTX)$ 4/A [Amend] Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000191 Size: 24 KB 网页链接查看全文
AN2 Therapeutics(ANTX)03-30 04:35
$AN2 Therapeutics(ANTX)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-038681 Act: 34 Size: 9 MB 网页链接查看全文
AN2 Therapeutics(ANTX)05-15 04:15
$AN2 Therapeutics(ANTX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-24-059556 Act: 34 Size: 6 MB 网页链接查看全文
AN2 Therapeutics(ANTX)06-22 06:25
$AN2 Therapeutics(ANTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-076410 Size: 17 KB 网页链接查看全文
AN2 Therapeutics(ANTX)06-25 04:15
$AN2 Therapeutics(ANTX)$ 8-K Current report, items 5.07 and 9.01 Accession Number: 0001193125-24-166938 Act: 34 Size: 199 KB 网页链接查看全文
AN2 Therapeutics(ANTX)04-27 04:25
$AN2 Therapeutics(ANTX)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0000950170-24-049172 Act: 34 Size: 1 MB 网页链接查看全文
同写意2022-04-19 21:22
编译丨Daisy
编辑丨于靖
2022年第一季度是三年来新股发行最慢的一个季度，迫使初创的制药企业在更艰难的融资环境中另寻出路。
想要上市的生物科技公司正面临着一个与一年前完全不同的世界。
行业股价暴跌，过去两年创下纪录的IPO步伐也因此放缓。初创的制药企业再也无法获得2021年...查看全文
$AN2 Therapeutics(ANTX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-23-021812 Act: 34 Size: 77 KB 网页链接
$AN2 Therapeutics(ANTX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000921895-23-000525 Act: 34 Size: 277 KB 网页链接
$AN2 Therapeutics(ANTX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-23-020803 Act: 34 Size: 140 KB 网页链接
$AN2 Therapeutics(ANTX)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000078003-23-000011 Act: 34 Size: 75 KB 网页链接
$AN2 Therapeutics(ANTX)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-23-019766 Act: 34 Size: 35 KB 网页链接
$AN2 Therapeutics(ANTX)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-23-032801 Act: 34 Size: 92 KB 网页链接
$AN2 Therapeutics(ANTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-035782 Size: 10 KB 网页链接
$AN2 Therapeutics(ANTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-035472 Size: 11 KB 网页链接
$AN2 Therapeutics(ANTX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-22-023901 Act: 34 Size: 9 MB 网页链接
$AN2 Therapeutics(ANTX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-22-023882 Act: 34 Size: 363 KB 网页链接